Return to study ST002523 main page
MB Sample ID: SA254510
| Local Sample ID: | MK279 |
| Subject ID: | SU002623 |
| Subject Type: | Human |
| Subject Species: | Homo sapiens |
| Taxonomy ID: | 9606 |
| Age Or Age Range: | 68 (63, 73) |
| Weight Or Weight Range: | 77 (62, 87) |
| Height Or Height Range: | 170 (160, 176) |
| Gender: | Male and female |
| Human Ethnicity: | White |
| Human Medications: | anti-PD-1 immune checkpoint inhibitors (nivolumab or pembrolizumab) |
| Human Inclusion Criteria: | consecutive advanced cancer patients |
Select appropriate tab below to view additional metadata details:
Sample Preparation:
| Sampleprep ID: | SP002629 |
| Sampleprep Summary: | Urine samples were then diluted 11 times in mobile phase eluent A and fortified with stable isotope labelled standards before analysis. |
